Efter at have gennemgået de foreliggende oplysninger konkluderede CHMP, at balancen mellem risici og fordele ved Protopic bør anses for gunstig.
After reviewing the available data the CHMP concluded that the balance of risks and benefits for Protopic is considered favourable.